Found: 105
Select item for more details and to access through your institution.
Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 2, p. 63, doi. 10.1002/acr2.11517
- By:
- Publication type:
- Article
Safety and Biological Activity of Rozibafusp alfa, a Bispecific Inhibitor of Inducible Costimulator Ligand and B Cell Activating Factor, in Patients With Rheumatoid Arthritis: Results of a Phase 1b, Randomized, Double‐Blind, Placebo‐Controlled, Multiple Ascending Dose Study
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 10, p. 903, doi. 10.1002/acr2.11487
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 408, doi. 10.1002/cpdd.251
- By:
- Publication type:
- Article
A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 259, doi. 10.1002/cpdd.237
- By:
- Publication type:
- Article
Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study.
- Published in:
- Drugs in R&D, 2021, v. 21, n. 3, p. 285, doi. 10.1007/s40268-021-00348-1
- By:
- Publication type:
- Article
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1857-3
- By:
- Publication type:
- Article
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1490-y
- By:
- Publication type:
- Article
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27945-7
- By:
- Publication type:
- Article
Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 2451, doi. 10.2147/PPA.S427809
- By:
- Publication type:
- Article
Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making.
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 119, doi. 10.2147/PPA.S220714
- By:
- Publication type:
- Article
Simulating clinical trial visits yields patient insights into study design and recruitment.
- Published in:
- Patient Preference & Adherence, 2017, v. 11, p. 1295, doi. 10.2147/PPA.S137416
- By:
- Publication type:
- Article
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Tocilizumab has no clinically relevant effects on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2012, v. 50, n. 3, p. 218, doi. 10.5414/CP201613
- By:
- Publication type:
- Article
Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 12, p. 1, doi. 10.1111/ijcp.14975
- By:
- Publication type:
- Article
A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
- Published in:
- Rheumatology, 2007, v. 46, n. 7, p. 1122, doi. 10.1093/rheumatology/kem033
- By:
- Publication type:
- Article
A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
- Published in:
- Rheumatology, 2007, v. 46, n. 7, p. 1122, doi. 10.1093/rheumatology/kem033
- By:
- Publication type:
- Article
A Randomized Clinical Trial to Evaluate Two Doses of an Intra-Articular Injection of LMWF-5A in Adults with Pain Due to Osteoarthritis of the Knee.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087910
- By:
- Publication type:
- Article
Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 2, p. 499, doi. 10.1007/s10067-021-05894-2
- By:
- Publication type:
- Article
Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 2, p. 437, doi. 10.1007/s10067-018-4276-y
- By:
- Publication type:
- Article
Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.
- Published in:
- Clinical Rheumatology, 2017, v. 36, n. 6, p. 1357, doi. 10.1007/s10067-017-3569-x
- By:
- Publication type:
- Article
General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 6, p. 918, doi. 10.1002/acr.24637
- By:
- Publication type:
- Article
Brief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Subcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 11, p. 1653, doi. 10.1002/acr.22384
- By:
- Publication type:
- Article
Twice Daily Versus Once Nightly Dosing of Pregabalin for Fibromyalgia: A Double-Blind Randomized Clinical Trial of Efficacy and Safety.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 2, p. 293, doi. 10.1002/acr.22111
- By:
- Publication type:
- Article
Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study.
- Published in:
- Arthritis Care & Research, 2013, v. 65, n. 5, p. 718, doi. 10.1002/acr.21876
- By:
- Publication type:
- Article
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0612-7
- By:
- Publication type:
- Article
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 95, doi. 10.1186/s13075-015-0612-7
- By:
- Publication type:
- Article
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee.
- Published in:
- Arthritis Research & Therapy, 2011, v. 13, n. 4, p. 1, doi. 10.1186/ar3430
- By:
- Publication type:
- Article
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 7, p. 663, doi. 10.3899/jrheum.2023-1062
- By:
- Publication type:
- Article
Safety and Efficacy of Poseltinib, Bruton's Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
- Published in:
- BMC Rheumatology, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41927-023-00329-8
- By:
- Publication type:
- Article
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
- Published in:
- Rheumatology, 2024, v. 63, n. 4, p. 1058, doi. 10.1093/rheumatology/kead333
- By:
- Publication type:
- Article
Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 10, p. 3268, doi. 10.1093/rheumatology/kead062
- By:
- Publication type:
- Article
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.
- Published in:
- Rheumatology, 2023, v. 62, n. 6, p. 2122, doi. 10.1093/rheumatology/keac605
- By:
- Publication type:
- Article
Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren's syndrome: a randomized, phase 2, double-blind, placebo-controlled study.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4797, doi. 10.1093/rheumatology/keac167
- By:
- Publication type:
- Article
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients.
- Published in:
- Rheumatology, 2022, v. 61, n. 3, p. 1035, doi. 10.1093/rheumatology/keab449
- By:
- Publication type:
- Article
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial.
- Published in:
- Rheumatology, 2021, v. 60, n. 1, p. 256, doi. 10.1093/rheumatology/keaa234
- By:
- Publication type:
- Article
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.
- Published in:
- Rheumatology, 2020, v. 59, n. 7, p. 1505, doi. 10.1093/rheumatology/kez471
- By:
- Publication type:
- Article
Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.
- Published in:
- Rheumatology, 2020, v. 59, n. 2, p. 292, doi. 10.1093/rheumatology/kez265
- By:
- Publication type:
- Article
261 Secukinumab 150 mg provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 4-year results from the Phase 3 trial, MEASURE 2.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study.
- Published in:
- Rheumatology, 2018, v. 57, n. 12, p. 2235, doi. 10.1093/rheumatology/key265
- By:
- Publication type:
- Article
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebocontrolled PALACE 4 trial.
- Published in:
- Rheumatology, 2018, v. 57, n. 7, p. 1253, doi. 10.1093/rheumatology/key032
- By:
- Publication type:
- Article
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
- Published in:
- Rheumatology, 2017, v. 56, n. 9, p. 1498, doi. 10.1093/rheumatology/kex174
- By:
- Publication type:
- Article
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3‐Year Results from the Phase 3 MEASURE 3 Study.
- Published in:
- ACR Open Rheumatology, 2020, v. 2, n. 2, p. 119, doi. 10.1002/acr2.11102
- By:
- Publication type:
- Article
Assessing usability, label comprehension, pen robustness and pharmacokinetics of a selfadministered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis.
- Published in:
- SAGE Open Medicine, 2014, v. 2, p. 1, doi. 10.1177/2050312114564241
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 4, p. 459, doi. 10.1002/jcph.826
- By:
- Publication type:
- Article